1. Home
  2. PD vs PTGX Comparison

PD vs PTGX Comparison

Compare PD & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$13.70

Market Cap

865.3M

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$146.04

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PD
PTGX
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
865.3M
9.3B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
PD
PTGX
Price
$13.70
$146.04
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$12.63
$108.23
AVG Volume (30 Days)
1.3M
437.4K
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
N/A
EPS
0.19
2.35
Revenue
$492,546,000.00
N/A
Revenue This Year
$3.58
$874.25
Revenue Next Year
$2.88
N/A
P/E Ratio
$74.05
$63.18
Revenue Growth
5.36
N/A
52 Week Low
$5.70
$57.90
52 Week High
$16.91
$160.81

Technical Indicators

Market Signals
Indicator
PD
PTGX
Relative Strength Index (RSI) 72.82 53.39
Support Level $6.08 $127.98
Resistance Level $15.36 $160.81
Average True Range (ATR) 0.54 5.71
MACD 0.13 -1.52
Stochastic Oscillator 88.00 34.55

Price Performance

Historical Comparison
PD
PTGX

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: